What are the potential benefits of a multidisciplinary approach to ALS research, involving basic scientists, clinicians, and engineers? 92

This Horizon Scan summarizes the available information regarding emerging drug therapies for the treatment of patients with amyotrophic lateral sclerosis. Oct 10, 2024 ... ... Information: Technical Assistance Webinars for RFA-NS-25-024 Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded ... Jan 9, 2019 ... ... informational tools for planning and assessing actions on forest management and conservation. ... We developed a method using ALS data combined ... Mar 24, 2025 ... The phase II FORTITUDE-ALS studyopens in a new tab or window of reldesemtiv reported trends favoring the drug but did not achieve statistical ... The following organizations are good resources for information on amyotrophic lateral sclerosis (ALS). ... informational purposes only and SHOULD NOT be ... The goal of this announcement is to support the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological ... Nov 16, 2023 ... Although data are preliminary, tofersen may offer hope to patients with familial ALS who have a mutation in the SOD1 gene. Since the drug was ... Oct 13, 2022 ... Furthermore, my interest in the notebooks was elevated when I realized I wanted to continue presenting while working through my current ALS ... Relevance of target to human disease · Pre-clinical data to support target and therapy · Clinical trial readiness (availability of compound and placebo (if ... Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under 'CRF Module/Guidance' on each disorder's data standards ...